BMJ23h
Lower limb arterial incompressibility and obstruction in rheumatoid arthritis
Division of Clinical Immunology and Rheumatology, Department of Medicine and the Frederic C Bartter General Clinical Research Center, University of Texas Health Science Center, San Antonio, Texas, USA ...
BMJ2d
AB1006 PULMONARY MANIFESTATIONS OF AXIAL SPONDYLOARTHRITIS (AXSPA): A SYSTEMATIC LITERATURE REVIEW
Background Common extra musculoskeletal manifestations (EMM) of axSpA include uveitis, inflammatory bowel disease, and psoriasis; and some of the uncommon manifestations include aortic incompetence, ...
BMJ3d
Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis
Correspondence to Professor Georg Schett, Department of Internal Medicine 3, Rheumatology and Immunology, University of Erlangen-Nuremberg, Ulmenweg 18, Erlangen 91054, Germany; ...
BMJ3d
Quadriceps weakness in knee osteoarthritis: the effect on pain and disability
a Rheumatology Unit, City Hospital, Nottingham NG5 1PB, b Department of Public Health Medicine and Epidemiology, Queens Medical Centre, Nottingham Dr O’Reilly. OBJECTIVES (1) To determine the ...
BMJ4d
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Correspondence to Professor Gabriela Riemekasten, Department of Rheumatology, University Hospital Schleswig-Holstein—Campus Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany; ...
BMJ4d
Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials
Objectives To describe short-term (up to 12 months) and long-term (up to 7 years) damage in patients with newly diagnosed antineutrophil-cytoplasm antibody-associated vasculitis (AAV). Methods Data ...
BMJ4d
Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis
1 Renal Institute of Birmingham, School of Infection, Immunity and Inflammation, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK Objective To contrast the effect of ...
BMJ4d
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet’s phenotype: a multicentre study
Objective To evaluate the effectiveness and safety of secukinumab in patients with a mucosal and articular Behçet’s phenotype resistant to conventional and biologic treatment. Methods A multicentre ...
BMJ4d
Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis
Correspondence to: Dr M Wada, Division of Rehabilitation Medicine, Fukui Medical University, Shimoaizuki 23, Matsuoka-cho, 910–1193, Fukui, Japan; mwada{at}do.mitene.ac.jp Objective: To test the ...
BMJ4d
Intra-articular hyaluronan treatment for osteoarthritis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ4d
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and immunological parameters with ...
BMJ4d
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
Objectives To develop and validate an international set of classification criteria for primary Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology (ACR) and the European ...